Becker's Healthcare April 12, 2019
While novel medical devices offer the promise of advanced treatment options and better outcomes for patients, the high costs associated with the devices and the lagging reimbursement structure create financial challenges for hospitals.
Hospitals often take a loss on new medical devices, which almost always carry a premium price and are rarely reimbursed adequately upon market introduction, according to a new Vizient report analyzing the costs of medical device innovation.
The report, “The Cost of Medical Device Innovation: Can We Keep Pace?,” looks at the pricing of new cardiovascular medical devices and how hospitals can develop processes to evaluate and adopt these and other technologies on a budget.
Five findings from the report:
1. New cardiovascular devices saw an average...